10-K Decoder · All companies

Acadia Pharmaceuticals Inc.

ACAD · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$1.07B$958M+11.9%
Operating income$105M$231M−54.6%
Net income$391M$226M+72.7%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$342M$279M+22.9%
Operating income$71.7M$35.8M+100%
Net income$53.5M$71.8M−25.5%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Acadia Pharmaceuticals's revenue in FY2025?
$1.07B in FY2025 (Fiscal year ended Dec 31, 2025), +11.9% vs $958M a year earlier, per its 10-K filed Feb 2026.
Was Acadia Pharmaceuticals profitable in FY2025?
Yes: net income was $391M and operating income $105M in FY2025.
What was Acadia Pharmaceuticals's revenue in Q3 2026?
$342M (+22.9% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.